Newsletters- studies- surveys

In a year marked by global uncertainty, shifting regulations and fast-moving innovation, leaders in the life sciences and pharmaceuticals sector are redefining their strategic priorities. Drawing on insights from executives from across more than 35 countries, our latest report captures how sector players are navigating complexity, investing in growth and positioning themselves for long-term success in a competitive landscape.

The international market may be volatile, but the outlook in the private equity (PE) sector shows increasing confidence. In this report, we uncover why PE firms remain optimistic for 2025 and what strategies they’re employing to drive investment.

Does the perceived reduction in risk amongst European banks hint at early signs of optimism for the sector? Throughout 2023, we observed a global economic slowdown, ongoing geopolitical tensions, and the rapid rise of new technologies. As we analyse the year-end results of the 26 largest banks in Europe, what do these figures reveal about expected credit losses and how these institutions manage persistent uncertainties in the banking landscape?

Has the European banking sector achieved renewed stability amidst a troubled macroeconomic context? Over the past three years, the banking sector has had to endure numerous crises, including Covid-19 and the war in Ukraine. What do the 2023 interim results of the 26 largest banks in Europe indicate about the impact on Expected Credit Losses (ECL) in this unusual environment?